| 10.1080/02688697.2022.2159925 |
36.576.058 |
4:resche-rigon,matthieu |
Relative survival after meningioma surgery. A French nationwide population-based cohort study. |
Br J Neurosurg |
2.022 |
|
1-7 |
| 10.1182/bloodadvances.2022009167 |
36.534.147 |
1:LAMBERT,Jerome |
Enriching single-arm clinical trials with external controls: possibilities and pitfalls. |
Blood Adv |
2.022 |
|
|
| 10.1186/s12874-022-01769-5 |
36.522.698 |
DA:BIARD,Lucie |
Challenges of using external data in clinical trials- an illustration in patients with COVID-19. |
BMC Med Res Methodol |
2.022 |
22 |
321 |
| 10.1001/jamanetworkopen.2022.46548 |
36.512.353 |
2:SERRET-LARMANDE,ARNAUD |
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic. |
JAMA Netw Open |
2.022 |
5 |
e2246548 |
| 10.3390/antibiotics11111664 |
36.421.308 |
3:LAMBERT,Jerome |
Empirical Antibiotic Therapy for Gram-Negative Bacilli Ventilator-Associated Pneumonia: Observational Study and Pharmacodynamic Assessment. |
Antibiotics (Basel) |
2.022 |
11 |
|
| 10.3324/haematol.2021.280051 |
36.263.839 |
ADA:LAMBERT,Jerome |
Prognostic value of positron emission tomography/computed tomography in transplanteligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study. |
Haematologica |
2.022 |
|
|
| 10.1002/sim.9591 |
36.259.523 |
DA:BIARD,Lucie |
Surv-CRM-12: A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression. |
Stat Med |
2.022 |
41 |
5753-5766 |
| 10.55563/clinexprheumatol/mm2uzu |
36.200.930 |
2:resche-rigon,matthieu |
Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis. |
Clin Exp Rheumatol |
2.022 |
|
|
| 10.1016/j.bulcan.2022.07.001 |
36.058.716 |
ADA:chevret,sylvie |
[What are the genetic practices of SFCE oncopediatricians? A study of the CONECT-AML ethical group]. |
Bull Cancer |
2.022 |
109 |
1162-1176 |
| 10.1016/j.neuchi.2022.08.001 |
36.030.926 |
DA:chevret,sylvie |
Gastrostomy and internal cerebrospinal fluid shunt in adults. A systematic review and meta-analysis of the risk of infection. |
Neurochirurgie |
2.022 |
68 |
e75-e83 |
| 10.2340/jrm.v54.736 |
36.017.667 |
8:LAMBERT,Jerome |
Feasibility and Safety of Active Physiotherapy in the Intensive Care Unit for Intubated Patients with Malignancy. |
J Rehabil Med |
2.022 |
|
jrm00299 |
| 10.14309/ajg.0000000000001842 |
35.973.142 |
ADA:LAMBERT,Jerome |
Efficacy and Safety of Infliximab Retreatment in Crohn”s Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID. |
Am J Gastroenterol |
2.022 |
117 |
1482-1490 |
| 10.1371/journal.pone.0270744 |
35.797.337 |
2:chevret,sylvie |
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. |
PLoS One |
2.022 |
17 |
e0270744 |
| 10.1007/s00464-021-08781-8 |
35.790.591 |
3:LAMBERT,Jerome |
Predictive factors for the success of endoscopic dilation of esophageal caustic stricture: the experience of a French tertiary reference center. |
Surg Endosc |
2.022 |
36 |
5660-5668 |
| 10.1001/jamainternmed.2022.2168 |
35.788.622 |
ADA:chevret,sylvie |
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial. |
JAMA Intern Med |
2.022 |
182 |
906-916 |
| 10.1371/journal.pone.0270138 |
35.767.521 |
2:LAMBERT,Jerome |
High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation. |
PLoS One |
2.022 |
17 |
e0270138 |
| 10.1128/spectrum.00636-22 |
35.730.967 |
9:chevret,sylvie |
Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients” Length of Stay in an Emergency Department. |
Microbiol Spectr |
2.022 |
10 |
e0063622 |
| 10.1007/s00018-022-04318-x |
35.708.858 |
19:chevret,sylvie |
Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19. |
Cell Mol Life Sci |
2.022 |
79 |
365 |
| 10.1038/s41746-022-00601-0 |
35.697.747 |
11:SERRET-LARMANDE,ARNAUD |
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality. |
NPJ Digit Med |
2.022 |
5 |
74 |
| 10.1093/rheumatology/keac319 |
35.686.921 |
8:resche-rigon,matthieu |
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous hematopoietic stem cell transplantation. |
Rheumatology (Oxford) |
2.022 |
|
|
| 10.1016/j.htct.2022.05.003 |
35.673.599 |
3:chevret,sylvie |
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival. |
Hematol Transfus Cell Ther |
2.022 |
|
|
| 10.1177/09622802221102623 |
35.658.734 |
2:resche-rigon,matthieu |
Multiple imputation for cause-specific Cox models: Assessing methods for estimation and prediction. |
Stat Methods Med Res |
2.022 |
31 |
1860-1880 |
| 10.1093/dote/doac032 |
35.649.393 |
2:resche-rigon,matthieu |
Emergency computed tomography evaluation of caustic ingestion. |
Dis Esophagus |
2.022 |
35 |
|
| 10.1111/bjh.18193 |
35.438.802 |
ADA:chevret,sylvie |
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM”s \”pick a winner\” trial, with the impact of somatic mutations. |
Br J Haematol |
2.022 |
198 |
535-544 |
| 10.1038/s41598-022-10218-8 |
35.418.602 |
2:chevret,sylvie |
The appropriate and sequential value of standard radiograph, computed tomography and magnetic resonance imaging to characterize a bone tumor. |
Sci Rep |
2.022 |
12 |
6196 |
| 10.1158/2159-8290.CD-21-0521 |
35.398.880 |
ADA:chevret,sylvie |
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon. |
Cancer Discov |
2.022 |
12 |
1435-1448 |
| 10.1161/STROKEAHA.121.034445 |
35.354.303 |
ADA:BIARD,Lucie |
Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis. |
Stroke |
2.022 |
53 |
1550-1557 |
| 10.1016/j.eclinm.2022.101362 |
35.350.097 |
58:resche-rigon,matthieu |
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group. |
EClinicalMedicine |
2.022 |
46 |
101362 |
| 10.1016/j.lana.2022.100216 |
35.308.034 |
ADA:chevret,sylvie |
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). |
Lancet Reg Health Am |
2.022 |
10 |
100216 |
| 10.1016/j.msard.2022.103744 |
35.305.427 |
2:LAMBERT,Jerome |
The frequent sign of a rare disease or the rare sign of a frequent disease? |
Mult Scler Relat Disord |
2.022 |
60 |
103744 |
| 10.1016/j.jtct.2022.03.014 |
35.302.009 |
3:SERRET-LARMANDE,ARNAUD |
Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. |
Transplant Cell Ther |
2.022 |
28 |
325.e1-325.e7 |
| 10.3324/haematol.2021.280567 |
35.295.081 |
4:LAMBERT,Jerome |
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial. |
Haematologica |
2.022 |
107 |
1726-1730 |
| 10.1016/S1470-2045(22)00097-3 |
35.279.271 |
2:BIARD,Lucie;4:resche-rigon,matthieu |
PD-1 blockade with pembrolizumab in classic or endemic Kaposi”s sarcoma: a multicentre, single-arm, phase 2 study. |
Lancet Oncol |
2.022 |
23 |
491-500 |
| 10.2196/35190 |
35.275.837 |
2:SERRET-LARMANDE,ARNAUD |
Mining Electronic Health Records for Drugs Associated With 28-day Mortality in COVID-19: Pharmacopoeia-wide Association Study (PharmWAS). |
JMIR Med Inform |
2.022 |
10 |
e35190 |
| 10.3390/cancers14051331 |
35.267.639 |
20:chevret,sylvie |
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy. |
Cancers (Basel) |
2.022 |
14 |
|
| 10.1186/s12874-022-01513-z |
35.220.954 |
DA:chevret,sylvie |
Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome. |
BMC Med Res Methodol |
2.022 |
22 |
54 |
| 10.1038/s41409-022-01620-x |
35.220.412 |
2:chevret,sylvie |
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT. |
Bone Marrow Transplant |
2.022 |
57 |
768-774 |
| 10.1080/10428194.2022.2032038 |
35.201.907 |
DA:LAMBERT,Jerome |
Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials. |
Leuk Lymphoma |
2.022 |
63 |
1544-1555 |
| 10.1016/j.semarthrit.2022.151981 |
35.183.934 |
ADA:resche-rigon,matthieu |
The shrinking toe sign in gout. |
Semin Arthritis Rheum |
2.022 |
53 |
151981 |
| 10.1001/jama.2022.2017 |
35.179.564 |
2:resche-rigon,matthieu;26:BIARD,Lucie |
Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge. |
JAMA |
2.022 |
327 |
1042-1050 |
| 10.1371/journal.pone.0262564 |
35.176.057 |
ADA:chevret,sylvie |
Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study. |
PLoS One |
2.022 |
17 |
e0262564 |
| 10.1016/j.ajo.2022.02.002 |
35.172.172 |
2:ANDRILLON,Anais;19:BIARD,Lucie |
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients. |
Am J Ophthalmol |
2.022 |
238 |
173-180 |
| 10.1093/jamiaopen/ooac001 |
35.156.003 |
1:SERRET-LARMANDE,ARNAUD |
Streamlining statistical reproducibility: NHLBI ORCHID clinical trial results reproduction. |
JAMIA Open |
2.022 |
5 |
ooac001 |
| 10.1097/HS9.0000000000000680 |
35.141.471 |
2:LAMBERT,Jerome |
What Prognostic Markers Should Be Evaluated in Marginal Zone Lymphoma? A Survey Among Leading International Experts. |
Hemasphere |
2.022 |
6 |
e680 |
| 10.1186/s12874-022-01506-y |
35.125.097 |
DA:chevret,sylvie |
Statistical methods for evaluating the fine needle aspiration cytology procedure in breast cancer diagnosis. |
BMC Med Res Methodol |
2.022 |
22 |
40 |
| 10.1183/13993003.02523-2021 |
35.115.337 |
4:resche-rigon,matthieu |
Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group. |
Eur Respir J |
2.022 |
60 |
|
| 10.14309/ajg.0000000000001667 |
35.103.020 |
3:BIARD,Lucie |
Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals. |
Am J Gastroenterol |
2.022 |
117 |
627-636 |
| 10.1038/s41409-021-01526-0 |
35.094.012 |
ADA:chevret,sylvie |
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma. |
Bone Marrow Transplant |
2.022 |
57 |
431-439 |
| 10.1158/1078-0432.CCR-21-3764 |
35.078.858 |
27:LAMBERT,Jerome |
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma. |
Clin Cancer Res |
2.022 |
28 |
1422-1432 |
| 10.1016/S0140-6736(21)02176-0 |
35.065.008 |
2:chevret,sylvie |
A three-step support strategy for relatives of patients dying in the intensive care unit: a cluster randomised trial. |
Lancet |
2.022 |
399 |
656-664 |
| 10.1136/rmdopen-2021-001846 |
35.042.728 |
2:chevret,sylvie |
Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohort. |
RMD Open |
2.022 |
8 |
|
| 10.1111/bjd.21018 |
35.041.763 |
3:ANDRILLON,Anais;5:BIARD,Lucie |
Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome. |
Br J Dermatol |
2.022 |
186 |
1010-1025 |
| 10.1111/liv.15159 |
35.025.128 |
ADA:chevret,sylvie |
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts. |
Liver Int |
2.022 |
42 |
1386-1400 |
| 10.1002/ijc.33928 |
35.001.364 |
13:Flicoteaux,Remi |
Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals. |
Int J Cancer |
2.022 |
150 |
1609-1618 |
| 10.1016/j.ophtha.2021.11.013 |
34.793.830 |
2:ANDRILLON,Anais;ADA:BIARD,Lucie |
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network. |
Ophthalmology |
2.022 |
129 |
520-529 |
| 10.1002/bimj.202000369 |
34.729.815 |
2:BIARD,Lucie;DA:chevret,sylvie |
DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses. |
Biom J |
2.022 |
64 |
1486-1497 |
| 10.1183/13993003.01017-2021 |
34.675.043 |
3:WALTER,Anouk;ADA:chevret,sylvie |
Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort. |
Eur Respir J |
2.022 |
59 |
|
| 10.1093/rheumatology/keab635 |
34.363.461 |
2:BIARD,Lucie |
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients. |
Rheumatology (Oxford) |
2.022 |
61 |
1376-1384 |
| 10.1007/s11239-021-02512-5 |
34.296.382 |
3:MONTLAHUC,Claire |
Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study. |
J Thromb Thrombolysis |
2.022 |
53 |
417-424 |
| 10.1038/s41375-021-01334-x |
34.183.766 |
10:chevret,sylvie |
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols. |
Leukemia |
2.022 |
36 |
263-266 |
| 10.1002/bimj.202000365 |
34.180.091 |
DA:chevret,sylvie |
Multiobjective semisupervised learning with a right-censored endpoint adapted to the multiple imputation framework. |
Biom J |
2.022 |
64 |
1446-1466 |
